Actuate Therapeutics Inc (ACTU)
R&D Expense Growth
-44.89%
Fiscal year · Period ending:
ACTU R&D Expense Growth
Latest reported-44.89%period ending
Latest reported-44.89%period ending
ACTU FY R&D Growth (YoY) (0.00% → -44.89%)
Latest values, visible window
High-resolution chart · PNG
ACTU r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -44.8893% | |
| -13.9672% | |
| 32.4711% | |
| 0% |